Annual Short Term Debt
$550.00 K
-$41.00 K-6.94%
31 March 2024
Summary:
VistaGen Therapeutics annual short term debt is currently $550.00 thousand, with the most recent change of -$41.00 thousand (-6.94%) on 31 March 2024. During the last 3 years, it has risen by +$182.20 thousand (+49.54%). VTGN annual short term debt is now -96.05% below its all-time high of $13.93 million, reached on 31 March 2015.VTGN Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$525.00 K
-$42.00 K-7.41%
30 September 2024
Summary:
VistaGen Therapeutics quarterly short term debt is currently $525.00 thousand, with the most recent change of -$42.00 thousand (-7.41%) on 30 September 2024. Over the past year, it has increased by +$6100.00 (+1.18%). VTGN quarterly short term debt is now -96.23% below its all-time high of $13.93 million, reached on 31 March 2015.VTGN Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VTGN Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.9% | +1.2% |
| 3 y3 years | +49.5% | +30.5% |
| 5 y5 years | +812.1% | +16.1% |
VTGN Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -6.9% | +49.5% | -64.6% | +30.5% |
| 5 y | 5 years | -6.9% | +812.1% | -64.6% | +42.7% |
| alltime | all time | -96.0% | >+9999.0% | -96.2% | >+9999.0% |
VistaGen Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $525.00 K(-7.4%) |
| June 2024 | - | $567.00 K(+3.1%) |
| Mar 2024 | $550.00 K(-6.9%) | $550.00 K(+2.7%) |
| Dec 2023 | - | $535.40 K(+3.2%) |
| Sept 2023 | - | $518.90 K(-59.7%) |
| June 2023 | - | $1.29 M(+117.8%) |
| Mar 2023 | $591.00 K(+36.4%) | $591.00 K(-33.7%) |
| Dec 2022 | - | $891.10 K(-24.9%) |
| Sept 2022 | - | $1.19 M(-19.9%) |
| June 2022 | - | $1.48 M(+242.0%) |
| Mar 2022 | $433.30 K(+17.8%) | $433.30 K(+2.1%) |
| Dec 2021 | - | $424.40 K(+5.5%) |
| Sept 2021 | - | $402.30 K(+5.7%) |
| June 2021 | - | $380.60 K(+3.5%) |
| Mar 2021 | $367.80 K(-1.4%) | $367.80 K(-18.9%) |
| Dec 2020 | - | $453.50 K(-34.7%) |
| Sept 2020 | - | $694.60 K(-8.4%) |
| June 2020 | - | $758.00 K(+103.1%) |
| Mar 2020 | $373.20 K(+518.9%) | $373.20 K(-0.5%) |
| Dec 2019 | - | $375.10 K(-17.0%) |
| Sept 2019 | - | $452.00 K(-14.3%) |
| June 2019 | - | $527.50 K(+774.8%) |
| Mar 2019 | $60.30 K(+6.7%) | $60.30 K(+16.0%) |
| Dec 2018 | - | $52.00 K(-56.1%) |
| Sept 2018 | - | $118.40 K(-35.6%) |
| June 2018 | - | $183.80 K(+225.3%) |
| Mar 2018 | $56.50 K(-1.2%) | $56.50 K(+22.0%) |
| Dec 2017 | - | $46.30 K(-57.0%) |
| Sept 2017 | - | $107.70 K(-35.9%) |
| June 2017 | - | $167.90 K(+193.5%) |
| Mar 2017 | $57.20 K | $57.20 K(+58.4%) |
| Dec 2016 | - | $36.10 K(-49.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2016 | - | $71.70 K(-32.9%) |
| June 2016 | - | $106.80 K(+138.9%) |
| Mar 2016 | $44.70 K(-99.7%) | $44.70 K(-40.3%) |
| Dec 2015 | - | $74.90 K(-30.3%) |
| Sept 2015 | - | $107.50 K(-69.0%) |
| June 2015 | - | $346.70 K(-97.5%) |
| Mar 2015 | $13.93 M(+553.2%) | $13.93 M(+94.7%) |
| Dec 2014 | - | $7.16 M(+88.9%) |
| Sept 2014 | - | $3.79 M(+8.7%) |
| June 2014 | - | $3.49 M(+63.4%) |
| Mar 2014 | $2.13 M(+197.1%) | $2.13 M(+133.6%) |
| Dec 2013 | - | $912.90 K(+17.4%) |
| Sept 2013 | - | $777.40 K(-3.2%) |
| June 2013 | - | $803.40 K(+11.9%) |
| Mar 2013 | $717.80 K(-5.7%) | $717.80 K(-23.8%) |
| Dec 2012 | - | $941.40 K(+14.5%) |
| Sept 2012 | - | $822.10 K(-15.9%) |
| June 2012 | - | $977.80 K(+28.5%) |
| Mar 2012 | $761.20 K(>+9900.0%) | $761.20 K(+30.6%) |
| Dec 2011 | - | $582.90 K(-83.9%) |
| Sept 2011 | - | $3.62 M(+576.1%) |
| June 2011 | - | $535.90 K(>+9900.0%) |
| Mar 2011 | - | $500.00(0.0%) |
| Dec 2010 | $500.00(0.0%) | $500.00(0.0%) |
| Sept 2010 | - | $500.00(0.0%) |
| June 2010 | - | $500.00(0.0%) |
| Mar 2010 | - | $500.00(0.0%) |
| Dec 2009 | $500.00(0.0%) | $500.00(0.0%) |
| Sept 2009 | - | $500.00(0.0%) |
| June 2009 | - | $500.00(0.0%) |
| Dec 2008 | $500.00 | $500.00(0.0%) |
| June 2008 | - | $500.00(0.0%) |
| Mar 2008 | - | $500.00 |
FAQ
- What is VistaGen Therapeutics annual short term debt?
- What is the all time high annual short term debt for VistaGen Therapeutics?
- What is VistaGen Therapeutics annual short term debt year-on-year change?
- What is VistaGen Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for VistaGen Therapeutics?
- What is VistaGen Therapeutics quarterly short term debt year-on-year change?
What is VistaGen Therapeutics annual short term debt?
The current annual short term debt of VTGN is $550.00 K
What is the all time high annual short term debt for VistaGen Therapeutics?
VistaGen Therapeutics all-time high annual short term debt is $13.93 M
What is VistaGen Therapeutics annual short term debt year-on-year change?
Over the past year, VTGN annual short term debt has changed by -$41.00 K (-6.94%)
What is VistaGen Therapeutics quarterly short term debt?
The current quarterly short term debt of VTGN is $525.00 K
What is the all time high quarterly short term debt for VistaGen Therapeutics?
VistaGen Therapeutics all-time high quarterly short term debt is $13.93 M
What is VistaGen Therapeutics quarterly short term debt year-on-year change?
Over the past year, VTGN quarterly short term debt has changed by +$6100.00 (+1.18%)